Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/1998
08/06/1998WO1998033906A1 Insecticidal gene and peptide
08/06/1998WO1998033892A1 Establishment of hhv-8+ lymphoma cell line, virus produced, antibody, diagnostic method and kit for detecting hhv-8 infection
08/06/1998WO1998033888A1 Peptides and peptide-loaded antigen presenting cells for the activation of ctl
08/06/1998WO1998033884A1 Renibacterium salmoninarum vaccine
08/06/1998WO1998033814A1 THE 74 KILODALTON OUTER MEMBRANE PROTEIN FROM $i(MORAXELLA CATARRHALIS)
08/06/1998WO1998033528A2 Induction of b cell tolerance
08/06/1998WO1998033527A2 Cancer immunotherapy with semi-allogeneic cells
08/06/1998WO1998033524A1 Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
08/06/1998WO1998033523A1 Vaccination methods and molecules
08/06/1998WO1998033522A1 Infectious bursitis vaccine
08/06/1998WO1998033520A1 pH-SENSITIVE LIPOSOMES AND OTHER TYPES OF ENCAPSULATED VACCINES CONTAINING IMMUNOMODULATORS, AND METHODS FOR MAKING AND USING SAME
08/06/1998WO1998033511A1 Structurally modified peptides resistant to peptidase degradation
08/06/1998WO1998033510A1 Restenosis/atherosclerosis diagnosis, prophylaxis and therapy
08/06/1998WO1998033487A1 Use of microparticles with adsorbed antigen to stimulate immune responses
08/06/1998WO1998033474A1 Use of oil from emu or rhea birds as trans-membrane carriers for delivery of drugs, peptides and vaccines
08/06/1998WO1998033470A2 Substituted perylenequinones for use in photodynamic therapy
08/06/1998WO1998033387A1 Tolerance to natural antibody antigens
08/06/1998WO1998033386A1 Method of delivering antigens for vaccination with a live vector
08/06/1998WO1998024906A3 Isolated mammalian monocyte cell genes; related reagents
08/06/1998WO1998023959A3 Diagnosis and treatment of insulin-dependent diabetes mellitus
08/06/1998WO1998019703A3 Pharmaceutical antigen-antibody preparation
08/06/1998WO1998010794A3 Antineoplastic conjugates of transferrin, albumin and polyethylene glycol
08/06/1998WO1998005682A3 Peptides corresponding or imitating at least one antigenic determinant of the hamagglutinin protein of mobillivirus
08/06/1998WO1998001462A3 Urogenital carcinoma TLP complex peptides and antibodies thereof
08/06/1998CA2279579A1 Insecticidal gene and peptide
08/06/1998CA2279544A1 Induction of b cell tolerance
08/06/1998CA2279542A1 Tolerance to natural antibody antigens
08/06/1998CA2279490A1 Glutrnagln amidotransferase - a novel essential translational component
08/06/1998CA2279366A1 Restenosis/atherosclerosis diagnosis, prophylaxis and therapy
08/06/1998CA2279344A1 Human c5a-like receptor
08/06/1998CA2278848A1 Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use
08/06/1998CA2278824A1 Infectious bursitis vaccine
08/06/1998CA2278678A1 Cancer immunotherapy with semi-allogeneic cells
08/06/1998CA2278189A1 Peptides and peptide-loaded antigen presenting cells for the activation of ctl
08/06/1998CA2277362A1 Substituted perylenequinones for use in photodynamic therapy
08/06/1998CA2222981A1 Promoter of the human endoglin gene and its use
08/05/1998EP0856520A1 Method of preparing a monoclonal antibody, monoclonal antibody, a pharmaceutical composition and a diagnostic reagent
08/05/1998EP0856314A1 Immunosuppressant
08/05/1998EP0856058A1 Cell-cycle checkpoint genes
08/05/1998EP0856056A1 Fibronectic binding protein b compounds
08/05/1998EP0856054A1 Monoclonal antibody br110 and uses thereof
08/05/1998EP0856051A1 Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof
08/05/1998EP0856050A1 Transforming growth factor alpha hi
08/05/1998EP0856010A1 Mammaglobin, antibodies thereto, and their use for detecting diseases of the breast
08/05/1998EP0856009A1 Cd6 ligand
08/05/1998EP0856005A1 The aiolos gene
08/05/1998EP0855919A1 Hormone immunomodulated induction of mucosal immune responses
08/05/1998EP0855918A1 Chicken interleukin-15 and uses thereof
08/05/1998EP0855914A1 Stable formulations of mhc-peptide complexes
08/05/1998EP0644930B1 Monoclonal antibody against the extra-villous trophoblast
08/05/1998EP0606391B1 Inhibition of vascular narrowing using anti-padgem antibodies
08/05/1998CN1189857A Recombinant MVA virus, and the use thereof
08/05/1998CN1189855A Vaccines against hepatitis C
08/05/1998CN1189853A High molecular weight major outer membrane protein of moraxella
08/05/1998CN1189840A Hybrid molecules between heat-labile enterotoxin and cholera toxin B subunits
08/05/1998CN1189839A Compsns. and methods for detecting and treating acquired immunodeficiency syndrome
08/05/1998CN1189838A Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide
08/05/1998CN1189538A Vaccines
08/05/1998CA2221687A1 Tumor necrosis related receptor, tr5
08/04/1998US5789567 Chicken infectious anemia virus vaccine
08/04/1998US5789564 Development of research diagnostic and production tools for pro-hormone convertases
08/04/1998US5789559 DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent
08/04/1998US5789554 Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells
08/04/1998US5789544 Gene expression for vaccines
08/04/1998US5789388 Vaccine against viruses associated with antibody-dependent-enhancement of viral infectivity
08/04/1998US5789384 Administering (cyclic) isoleucine-tryptophan dipeptide, tripeptide, or its polymer to treat immunodeficiency
08/04/1998US5789237 Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor
08/04/1998US5789233 Amino acid sequence that selectively binds with antibody; for preparation of a vector vaccine against coccidiosis.
08/04/1998US5789232 Homogenizing and centrifuging infected animal cells with a glycine buffer
08/04/1998US5789231 Marek's disease vaccine
08/04/1998US5789229 Stranded RNA virus particles
08/04/1998US5789218 DNA encoding valyl tRNA synthetase from Staphylococcus aureus
08/04/1998US5789217 Protection against bacterial infections
08/04/1998US5789200 Polypeptides and dna(rna) codes by genetic engineering for diagnosis and treatment of cancer, prostate, breast, lung or epithelial tumors
08/04/1998US5789194 Parasitic helminth venom allergen antigen 5-like genes and proteins
08/04/1998US5789192 Mammalian receptors for interleukin-10 (IL-10)
08/04/1998US5789177 Glycorproteins, antibodies, and diagnostic kits for detection of bovine herpesvirus type 1
08/04/1998US5789176 Identification of a new Ehrlichia species from a patient suffering from Ehrlichiosis
08/04/1998US5789153 Method of quantitating nucleic acid
08/04/1998US5788985 Comprising n-glycidyl ganglioside coupled to carier protein, adjuvant
08/04/1998US5788970 Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
08/04/1998US5788969 Peptides for inducing cytotoxic T lymphocyte responses hepatitis B virus
08/04/1998US5788968 Oral administration of major histocompatibility complex antigen
08/04/1998US5788963 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
08/04/1998US5788962 DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures
08/04/1998CA2098296C Pseudomonas peptide composition and method for producing the same
08/04/1998CA1339980C Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same
08/03/1998CA2220852A1 Tumor necrosis related receptor, tr4
07/1998
07/30/1998WO1998033068A1 Method of growing ehrlichia phagocytophila in a promyelocytic leukemia cell culture and antigens and vaccines thereof
07/30/1998WO1998032873A1 New method for isolating polysaccharides
07/30/1998WO1998032865A1 Novel prostate-associated kallikrein
07/30/1998WO1998032862A2 L-alanine dehydrogenase of mycobacterium marinum
07/30/1998WO1998032855A1 Lage-1 tumor associated nucleic acids
07/30/1998WO1998032769A1 Antigen
07/30/1998WO1998032768A1 H. pylori antigens
07/30/1998WO1998032462A1 Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination
07/30/1998WO1998032461A1 Mutant enterotoxin effective as a non-toxic adjuvant for hiv
07/30/1998WO1998032456A1 Identification of broadly reactive dr restricted epitopes
07/30/1998WO1998032451A1 Treatment of autoimmune disease using tolerization in combination with methotrexate
07/30/1998WO1998032431A1 Antigen inducers, vaccine precursors, vaccines, antibodies, neutralizing antibodies, antitoxins, idiotypic antibodies, and anti-idiotypic antibodies induced by the idiotypic antibodies